BLK – B-cell lymphoid kinase – В-клеточная лимфоидная киназа;
CASP3 – caspase 3 – Каспаза-3;
FCGR – Fcγ receptor – Fcγ рецептор;
GWAS – genome-wide association study – исследование общегеномных ассоциаций;
HLA – human leukocyte antigen – антиген лейкоитов человека;
IgG – immunoglobulin G – иммуноглобулин G;
ITPKC – inositol 1,4,5-trisphosphate kinase-C – инозитол 1,4,5-трифосфат киназа-С;
KD – Kawasaki disease – БолезньКавасаки;
NFAT – nuclear factor of activated T cells – нуклеарный фактор активированных Т-клеток;
TDT – transmission disequilibrium test – тест неравновесной передачи.
Использованная литература: 1. Baker, AL, Lu, M, Minich, LL, Atz, AM, Klein, GL, Korsin, R, Lambert, L, Li, JS, Mason, W, Radojewski, E, Vetter, VL, Newburger, JW;
Pediatric Heart Network Investigators. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr. 2009;154:592–595.e2. doi: 10.1016 /j.jpeds. 2008.10.006.
Crossref.
PubMed.
1. Burns JC, Glodé MP.
Kawasaki syndrome. Lancet. 2004;
364 (9433): 533–544 pmid:15302199
CrossRefPubMedGoogle Scholar 2. Burns, JC, Shike, H, Gordon, JB, Malhotra, A, Schoenwetter, M, Kawasaki, T.
Sequelae of Kawasaki diseasein adolescents and young adults. J Am Coll Cardiol. 1996;28:253–257.
Crossref.
PubMed.
3. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS.
Association between a novel humancoronavirus and Kawasaki disease. J Infect Dis. 2005;
191(4):499–502pmid:15655771
Abstract/FREE Full Text Google Scholar 4. Jaggi, P, Kajon, AE, Mejias, A, Ramilo, O, Leber, A.
Human adenovirus infection in Kawasaki disease: a confounding bystander? Clin Infect Dis. 2013;56:58–64. doi: 10.1093/cid/cis807.
Crossref.
PubMed.
5. Kushner, HI, Bastian, JF, Turner, CL, Burns, JC.
The two emergencies of Kawasaki syndrome and the implications for the developing world. Pediatr Infect Dis J. 2008;27:377–383.
doi: 10.1097/INF.0b013e318166d795.
Crossref.
PubMed.
6. Nakamura, Y, Hirose, K, Yanagawa, H, Kato, H, Kawasaki, T.
Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr. 1994;83:1061–1064.
Crossref.
PubMed.
7. Rowley AH, Wolinsky SM, Relman DA, et al.
Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res. 1994;
36(5):567–571pmid:7877872
CrossRefPubMedGoogle Scholar 8. Shimizu, C, Jain, S, Davila, S, Hibberd, ML, Lin, KO, Molkara, D, Frazer, JR, Sun, S, Baker, AL, Newburger, JW, Rowley, AH, Shulman, ST, Burgner, D, Breunis, WB, Kuijpers, TW, Wright, VJ, Levin, M, Eleftherohorinou, H, Coin, L, Popper, SJ, Relman, DA, Fury, W, Lin, C, Mellis, S, Tremoulet, AH, Burns, JC.
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet. 2011;4:16–25. doi: 10.1161 /CIRCGENETICS. 110.940858.
Crossref.
PubMed.
9. Shimizu C, Shike H, Baker SC, et al.
Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J Infect Dis. 2005;192(10):1767–1771pmid:16235175
Abstract/FREE Full TextGoogle Scholar 10. Shulman ST, Rowley AH.
Does Kawasaki disease have a retroviral aetiology? Lancet. 1986;2(8506):545–546pmid:2427900
Cross Ref Pub Med Google ScholarSon MB, Newburger JW.
Kawasaki disease. Pediatr Rev. 2013;
34(4): 151–162 pmid:23547061
FREE Full TextGoogle Scholar 11. Turnier J.L., Anderson M.S., Heizer H.R., Jone P.-N., Glodé M.P., Domin -guez S.R.
Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015; 136 (3). Available at:
www. Pediatrics.org /cgi /content /full /136/3/e609 Google Scholar 12. Uehara, R, Belay, ED.
Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79–85.
Cross ref.
PubMed.
13. Jordan-Villegas A, Chang ML, Ramilo O, Mejías A.
Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J. 2010;29(8):770–772pmid:20354462
CrossRefPubMedGoogle Scholar